Trial Profile
Planned phase III trial of RUT58-60.
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 14 Apr 2015
Price :
$35
*
At a glance
- Drugs RUT 58 60 (Primary)
- Indications Infections
- Focus Registrational; Therapeutic Use
- Sponsors Ruthigen
- 14 Apr 2015 Planned initiation date changed to 1 Dec 2015.
- 29 Mar 2014 New trial record